D. Thomas Oakley

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.

Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.

ChanTest Corp. provided testing and discovery services to pharmaceutical and biotech companies. Its services included safety, discovery, cell biology and transporters. The company was founded by Arthur M. Brown in 1998 and was headquartered in Cleveland, OH.

MPI Research, Inc. provides preclinical research and development services. It offers drug safety, discovery sciences, bio-analytical and analytical solutions, surgical services, medical device evaluation, and specialty services. The company was founded by William U. Parfet in 1995 and is headquartered in Mattawan, MI.

Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ.